Dairy Choline Bioavailability in Post-menopausal Women

This study is looking at how well your body uses choline from dairy compared to eggs. Researchers want to understand how the body processes choline and what effect Whey Protein Phospholipid Concentrate (WPPC) has on this process. They will compare WPPC to whole egg powder to see if WPPC is just as effective as eggs in providing choline. You would drink a chocolate-flavored drink containing either WPPC or whole egg powder. This study is for women aged 51 to 70 who are post-menopausal (meaning your menstrual periods have stopped permanently for at least 12 months). The main goal is to measure changes in choline levels in your blood over 10 days. The current recruitment status is unclear, and the study plans to enroll 24 participants.

Study design
This is an interventional study planning to enroll 24 post-menopausal women aged 51-70.
What's involved
Participants will drink a chocolate-flavored drink with either WPPC or whole egg powder. Choline levels will be measured from baseline to 10 days.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 10 days after the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06902480

Dairy Choline Bioavailability

Not Yet Recruiting
NAAges 51–70Interventional
University of Wisconsin, Madison
~24 participants
Updated 2026-08-28 on ClinicalTrials.gov
What's tested:WPPCWhole egg powder

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in circulating choline
Measured over Baseline to 10 days
Post-menopausal Women
Post-menopausal Status
1 sites across 1 states
Wisconsin1
  • Bradley Bolling, PhD · PRINCIPAL_INVESTIGATOR · University of Wisconsin, Madison

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Ages between 51 and 70
Is currently post-menopausal (Post-menopausal is a term used to describe the time in a woman's life after she has gone through menopause. This usually happens between the ages of 45 and 55. Menopause is when a woman's menstrual periods stop permanently (at least 12 months))
Not allergic to the intervention foods and allergens that are related to the production of intervention foods (e.g. dairy products, egg, fish, peanut, shellfish, soy, tree nuts, wheat, crustaceans, gluten, mollusks, mustard, sesame seeds.)
Had stable body weight (± 5%) for the past 6 months
Free from cancer
Did not have weight loss surgery, colon surgery
Do not have chronic kidney diseases
Do not have malabsorption towards fat and dairy products
Willing to complete health surveys
Willing to complete two 4-day food diaries
Willing to consume the intervention smoothies
Willing to provide blood, urine, fecal samples at baseline and after 10 days of intervention

Exclusion

On weight loss/weight gain diets
Diagnosed with fat malabsorption
Undergoing weight loss surgery
Diagnosed with chronic kidney diseases
Allergic to the intervention foods and allergens that are related to the production of intervention foods (e.g. dairy products, egg, chocolate, fish, peanut, shellfish, soy, tree nuts, wheat, crustaceans, gluten, mollusks, mustard, sesame seeds, banana, strawberry, raspberry, blackberry, blueberry.)
Regularly using antibiotics or probiotics or prebiotics
Regularly using weight-loss drugs (GLP-1, Orlistat, Cetilistat, etc.)
Regularly using laxatives
Unable to avoid strenuous exercise during the study (\>4 h vigorous exercise per day)
  • Change in circulating cholineBaseline to 10 days

    Circulating choline will be measured by UHPLC-HRMS/MS